Feature | April 08, 2013

Transesophageal Echocardiograms on Patients With Known Clots May Be Overused

The American Society of Echocardiography releases list of “Five Things Physicians and Patients Should Question”

Transesophageal Echocardiogram

April 8, 2013 — The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Fifth on the list, they ask that patients and their doctors talk about the real need for a transesophageal echocardiography (TEE) if the patient’s clot treatment is not likely to be modified.

Avoid TEE to detect cardiac sources of embolization, if a source has been identified and patient management will not change.

TEE involves taking echo pictures from within the body to allow the imaging device to be placed directly next to the heart, so the quality of the images is enhanced and allows for identification of possible sources of a stroke including blood clots within the heart. Placing the imaging probe into the mouth and then advancing it into the esophagus of the patient on whom it is performed, is not without risk. In order to do this safely and comfortably, sedatives are administered and a local anesthetic is gargled in the mouth. Both the administration of these medications and placing of the probe in the esophagus are not entirely benign procedures, and, while complications rarely occur, there is a possibility of damage to the esophagus and choking or aspiration. Because of these risk factors, the procedure should only be done when the care of the patient will possibly change based upon the result.

When clots are thought to be the cause of a stroke and their source has been identified, blood thinners are usually started to prevent a second stroke. In some cases, doctors make the decision to use blood thinners such as warfarin or Coumadin even when there is no definite clot found. In other cases, these blood thinners are contraindicated due to a problem with bleeding. In both of these scenarios, further information about the cardiac source would not change the treatment thus even the small risk of the TEE is not justified.

For more information: www.choosingwisely.org, www.asecho.org

Related Content

ultrasound-activated microbubbles, heart attack, pig model, NIBIB, human clinical trials

An ultrasound-stimulated microbubble burrows through a fibrin clot (green) allowing penetration of the surrounding fluid into the clot (yellow). Image courtesy of Christopher Acconci and David Goertz, University of Toronto.

News | Ultrasound Imaging| February 11, 2016
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) used ultrasound-activated...
Alpha Source, data study, ultrasound equipment, total cost of ownership
News | Cardiovascular Ultrasound| February 01, 2016
Alpha Source, a Milwaukee-based provider of healthcare technology management solutions, announced the publication of a...
AMA, investigational CPT code, myocardial strain imaging, cardio-oncology
News | Cardiovascular Ultrasound| January 27, 2016
Effective Jan. 1, 2016, the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel...
Technology | Ultrasound Intra-cardiac Echo (ICE)| January 26, 2016
Conavi Medical Inc. (formerly Colibri Technologies Inc.) has received U.S. Food and Drug Administration (FDA) 510(k)...
Fujifilm, SonoSite Edge II, portable ultrasound system, FDA and CE clearance
Technology | Ultrasound Imaging| January 26, 2016
January 26, 2016 — Fujifilm SonoSite Inc. announced CE mark and U.S.
Sponsored Content | Case Study | Cardiovascular Ultrasound| January 21, 2016
This case study is from the Cardiac Imaging Department, Hospital Clinic, Barcelona, Spain.
Csound, GE ultrasound

4D Clarity, HDlive and cSound acquisition provide excellent TTE and TEE images.

Sponsored Content | Case Study | January 21, 2016
GE Healthcare is taking the next leap in image quality performance, quantification and workflow with the introduction
Cath lab radiation dose reduaction, doseaware, raysafe

The Philips DoseAware Xtend system is an advanced version of the Unfors RaySafe system, combining real time radiation detection badges and a live video screen showing each person in the cath lab in a different color. The system reports their real-time exposure rate and cumulative dose since the start of a procedure. It shows changes in dose exposure the closer a person gets to the C-arm.

Feature | Cardiac Imaging| January 12, 2016 | Dave Fornell
Each year radiology vendors use the Radiological Society of North America (RSNA) meeting as a springboard to unveil t
Fujifilm VisualSonics, Vevo MD, UHF, ultra-high frequency ultrasound, CE Mark
Technology | Cardiovascular Ultrasound| January 11, 2016
Fujifilm VisualSonics Inc. announced CE mark for the Vevo MD, what the company calls the world’s first ultra-high...
ASE, guidelines, echocardiography, cardiac sources of stroke, embolism
News | Cardiovascular Ultrasound| January 07, 2016
Stroke is the third leading cause of death in the Western industrialized world, and according to the Centers for...
Overlay Init